Lyumjev ® (insulin lispro)

För fullständig produktresumé för Lyumjev se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Lyumjev® ▼ (insulin lispro): Användning hos patienter med COVID-19 (Coronavirus sjukdom 2019)

Användningen av Lyumjev hos patienter med COVID-19 (coronavirus sjukdom 2019) har inte studerats.

Use of Lyumjev when having COVID-19

Continue your medication as your doctor has told you. If you think your medication should be changed, check with your doctor or pharmacist first. Your doctor will tell you if changes to your medication are necessary.

Tell your doctor when you think you might have COVID-19. Your doctor will help you to manage COVID-19 and to maintain good glyceamic control during infection and recovery.

Lilly has not studied the use of Lyumjev in patients with COVID-19 nor in patients at risk of contracting COVID-19.

Therefore it is unknown, whether patients using Lyumjev

  • are at higher or lower risk of contracting COVID-19, or

  • are at higher or lower risk of severe COVID-19

than patients not using Lyumjev.

Infectious Disease Resources for COVID-19

For current information on COVID-19, please refer to

References

1. Coronavirus disease (COVID-19) outbreak. World Health Organization Europe. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov

2. International Diabetes Federation Europe. COVID-19 outbreak: guidance for people with diabetes. https://www.idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html. Accessed March 18, 2020

3. COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china

Glossary

COVID-19 = coronavirus disease 2019

Lilly = Eli Lilly and Company

EU WHO = World Health Organization (European regional office)

IDF = International Diabetes Federation

ECDC = European Centre for Disease Prevention and Control

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Datum fӧr senaste ӧversyn March 18, 2020


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Klicka för att chatta är tillgänglig

Klicka för att chatta är offline

Skriv din fråga till oss